Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT00219934
Eligibility Criteria:
Inclusion Criteria:
* Group A: HIV-1 infected individuals at least 16 years of age with HIV-1 RNA detectable in the blood (\>2000 copies/ml) and one of the following:
1. a negative test for HIV-1 antibodies
2. an indeterminate test for HIV-1 antibodies
3. a positive test for HIV-1 antibodies with an immature Western Blot (less than 5 bands) which subsequently matures (addition of 2 or more bands)
4. a positive test for HIV-1 antibodies and a documented negative test within 6 months of presentation
5. a positive test for HIV-1 antibodies with a simultaneous negative low sensitivity ("detuned") assay (S/C \<15)
6. Individuals must be able and willing to provide written informed consent
Group B: Approximately 90 individuals diagnosed with acute HIV-1 infection in the past who have been participating in an ADARC/Rockefeller University Hospital protocol involving treatment of acute HIV-1 infection and are currently on that regimen with HIV-1 RNA consistently less than 50 copies/ml and are interested in changing to a protease inhibitor-sparing regimen or may continue to be treated with medications provided or taken as part of a completed ADARC/RUH study of the treatment of acute and early HIV infection
Exclusion Criteria:
* Individuals less than 16 years of age
* Individuals who are unable or unwilling to provide written informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00219934
Study Brief:
Protocol Section:
NCT00219934